[Correspondence] CSF dynamics in idiopathic normal pressure hydrocephalus

Author profile image Aggregator
0 comments
I read with interest the Article on the DRAIN trial by Virhammar and colleagues,1 which provides the first randomised evidence that acetazolamide does not improve gait in idiopathic normal pressure hydrocephalus. In a subgroup of patients (n=20; 11 received acetazolamide and 9 received placebo) who underwent brain MRI both before randomisation and at a 3-month in-person follow-up, acetazolamide was associated with reductions in periventricular white matter hyperintensity volume (−3·77 mL, 95% CI −5·58 to −1·95) and lateral ventricular volume (−4·40 mL, −6·79 to −2·01) compared with placebo.

Source: The Lancet Neurology - Current Issue Published 30 Nov 2026 Imported 19 Nov 2026 Relevancy: Not reviewed

Read the article